5.84
price down icon0.68%   -0.04
after-market Handel nachbörslich: 1.90 -3.94 -67.47%
loading
Schlusskurs vom Vortag:
$5.88
Offen:
$5.75
24-Stunden-Volumen:
23,655
Relative Volume:
0.04
Marktkapitalisierung:
$37.22M
Einnahmen:
$500.00K
Nettoeinkommen (Verlust:
$-7.88M
KGV:
-3.4475
EPS:
-1.694
Netto-Cashflow:
$-5.49M
1W Leistung:
+4.66%
1M Leistung:
-19.89%
6M Leistung:
-17.86%
1J Leistung:
-35.04%
1-Tages-Spanne:
Value
$5.75
$5.99
1-Wochen-Bereich:
Value
$5.5801
$6.04
52-Wochen-Spanne:
Value
$3.1006
$15.91

Exicure Inc Stock (XCUR) Company Profile

Name
Firmenname
Exicure Inc
Name
Telefon
847-673-1707
Name
Adresse
2430 N. HALSTED ST., CHICAGO, IL
Name
Mitarbeiter
8
Name
Twitter
@exicure
Name
Nächster Verdiensttermin
2024-08-12
Name
Neueste SEC-Einreichungen
Name
XCUR's Discussions on Twitter

Vergleichen Sie XCUR mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
0.625 0 0 0 0 0.00
 icon
MOBBW
Mobilicom Limited Warrants
3.65 4.83B 0 0 0 0.00
 icon
PSNYW
Polestar Automotive Holding Uk
4.66 416.27M 2.07B -1.42B -1.37B -0.6765
 icon
GOODO
Gladstone Commercial Corporation
20.75 372.90M 0 0 0 0.00
 icon
SHMD
Schmid Group N V
8.57 357.42M 0 0 0 0.00
 icon
DWLD
Davis Select Worldwide ETF
47.51 0 0 0 0 0.00

Exicure Inc Stock (XCUR) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2021-12-13 Herabstufung Chardan Capital Markets Buy → Neutral
2020-12-18 Eingeleitet BMO Capital Markets Outperform
2019-11-20 Eingeleitet Guggenheim Buy

Exicure Inc Aktie (XCUR) Neueste Nachrichten

pulisher
Jan 09, 2026

Why Exicure Inc. (2H0) stock attracts HNW investorsJuly 2025 Rallies & Stepwise Entry and Exit Trade Signals - ulpravda.ru

Jan 09, 2026
pulisher
Jan 08, 2026

Exicure HiTron sells $3.3m in Exicure shares By Investing.com - Investing.com Australia

Jan 08, 2026
pulisher
Jan 08, 2026

Exicure Hitron Sells Over 740K Shares - TradingView — Track All Markets

Jan 08, 2026
pulisher
Jan 08, 2026

Exicure HiTron sells $3.3m in Exicure shares - Investing.com

Jan 08, 2026
pulisher
Jan 08, 2026

Insider Sale: 10% owner at $XCUR Sells 741,272 Shares - Quiver Quantitative

Jan 08, 2026
pulisher
Jan 08, 2026

Why Exicure Inc. stock is rated strong buyMarket Growth Review & Daily Stock Trend Watchlist - ulpravda.ru

Jan 08, 2026
pulisher
Jan 06, 2026

Avoiding Lag: Real-Time Signals in (XCUR) Movement - Stock Traders Daily

Jan 06, 2026
pulisher
Jan 06, 2026

Bond Watch: Why Exicure Inc 2H0 stock attracts HNW investorsWeekly Loss Report & Low Volatility Stock Suggestions - moha.gov.vn

Jan 06, 2026
pulisher
Jan 02, 2026

Aug Highlights: Is Exicure Inc 2H0 stock worth buying before Fed actionWeekly Risk Report & Verified Short-Term Trading Plans - moha.gov.vn

Jan 02, 2026
pulisher
Dec 31, 2025

Exicure (XCUR) Stock Soars on Burixafor Phase 2 Data: What December 2025 Investors Need to Know - ts2.tech

Dec 31, 2025
pulisher
Dec 30, 2025

Promising Biotech Stocks To Keep An Eye OnDecember 9th - MarketBeat

Dec 30, 2025
pulisher
Dec 30, 2025

Buyback Watch: Is Exicure Inc 2H0 stock worth buying before Fed action2025 Key Highlights & Free Fast Gain Swing Trade Alerts - moha.gov.vn

Dec 30, 2025
pulisher
Dec 28, 2025

Exicure Regains Nasdaq Compliance as of July 2025 - The Globe and Mail

Dec 28, 2025
pulisher
Dec 28, 2025

Trading Action: Why Exicure Inc stock is rated strong buyAnalyst Downgrade & Free High Accuracy Swing Entry Alerts - moha.gov.vn

Dec 28, 2025
pulisher
Dec 26, 2025

(XCUR) Risk Channels and Responsive Allocation - Stock Traders Daily

Dec 26, 2025
pulisher
Dec 24, 2025

Exicure presents topline data from burixafor combination trial - MSN

Dec 24, 2025
pulisher
Dec 19, 2025

Will Exicure Inc. stock benefit from upcoming earnings reportsM&A Rumor & Accurate Intraday Trading Signals - DonanımHaber

Dec 19, 2025
pulisher
Dec 18, 2025

Is Exicure Inc. stock ready for breakoutMarket Trend Review & Technical Confirmation Trade Alerts - ulpravda.ru

Dec 18, 2025
pulisher
Dec 16, 2025

Exicure stock soars 40% after stem cell drug helps most patients hit phase 2 goal — traders call it 'cheap' at current levels - MSN

Dec 16, 2025
pulisher
Dec 15, 2025

Trading the Move, Not the Narrative: (XCUR) Edition - Stock Traders Daily

Dec 15, 2025
pulisher
Dec 15, 2025

Argenx, ServiceNow And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga

Dec 15, 2025
pulisher
Dec 13, 2025

Exit Recap: Will Exicure Inc stock recover faster than marketSwing Trade & Real-Time Chart Pattern Alerts - moha.gov.vn

Dec 13, 2025
pulisher
Dec 12, 2025

Promising Biotech Stocks To Keep An Eye On – December 9th - Defense World

Dec 12, 2025
pulisher
Dec 10, 2025

Sangsangin investment sells Exicure (XCUR) shares worth $3.77 million By Investing.com - Investing.com Nigeria

Dec 10, 2025
pulisher
Dec 10, 2025

XCUR Insider Trading - Quiver Quantitative

Dec 10, 2025
pulisher
Dec 10, 2025

Sangsangin Investment & Securities Sells All Exicure Shares - TradingView — Track All Markets

Dec 10, 2025
pulisher
Dec 10, 2025

Shareholder Sangsangin Investment & Securities Co Ltd Sells 433,332 ($3.8M) Of Exicure Inc [XCUR] - TradingView — Track All Markets

Dec 10, 2025
pulisher
Dec 10, 2025

Exicure’s Risky Bet On Stem Cell Mobilization Pays Early Dividends - Finimize

Dec 10, 2025
pulisher
Dec 10, 2025

Morning Market Movers: ASPC, ENVB, AFJK, JXG See Big Swings - RTTNews

Dec 10, 2025
pulisher
Dec 09, 2025

Exicure’s Stunning Rise: What’s Fueling It? - StocksToTrade

Dec 09, 2025
pulisher
Dec 09, 2025

Exicure Shares Surge 41% On Promising Phase 2 Data For Multiple Myeloma Drug - Nasdaq

Dec 09, 2025
pulisher
Dec 09, 2025

Exicure Stock Soars 40% After Stem Cell Drug Helps Most Patients Hit Phase 2 Goal — Traders Call It ‘Cheap’ At Current Levels - Stocktwits

Dec 09, 2025
pulisher
Dec 09, 2025

Exicure Rally Fueled By Rapid Cell-Boosting Results In Blood Cancer Trial - Benzinga

Dec 09, 2025
pulisher
Dec 09, 2025

Top Gainers on the US Stock Market Today (December 9, 2025): AFJK, NCPL, XCUR, ALEX and More Surge as Fed Meeting Looms - ts2.tech

Dec 09, 2025
pulisher
Dec 09, 2025

Exicure (XCUR) Stock: Biotech Soars on Promising Cancer Drug Data - parameter.io

Dec 09, 2025
pulisher
Dec 09, 2025

ASH: Exicure rebounds with phase 2 win, seeing 90% blood cell mobilization in myeloma - Fierce Biotech

Dec 09, 2025
pulisher
Dec 09, 2025

Dow Surges Over 100 Points; Campbell's Posts Upbeat Earnings - Benzinga

Dec 09, 2025
pulisher
Dec 09, 2025

This BlackRock stock just rocketed 70% - Finbold

Dec 09, 2025
pulisher
Dec 09, 2025

Exicure (XCUR) Stock: Biotech Shares Surge 140% on Cancer Drug Breakthrough - Blockonomi

Dec 09, 2025
pulisher
Dec 09, 2025

Exicure Inc.: Is It a Bet Worth Taking? - timothysykes.com

Dec 09, 2025
pulisher
Dec 09, 2025

Exicure Inc (XCUR) expanding its growth trajectory ahead - setenews.com

Dec 09, 2025
pulisher
Dec 09, 2025

Pre Market Movers: XCUR, VOR, MTVA Set The Path - RTTNews

Dec 09, 2025
pulisher
Dec 09, 2025

Morning Market Movers: ATMC, XCUR, VOR, ATMV See Big Swings - RTTNews

Dec 09, 2025
pulisher
Dec 09, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Dec 09, 2025

Finanzdaten der Exicure Inc-Aktie (XCUR)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Exicure Inc-Aktie (XCUR) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
SANGSANGIN INVESTMENT & SECURI
10% Owner
Dec 08 '25
Sale
8.71
433,332
3,774,322
0
$106.87
price up icon 0.90%
$34.26
price up icon 1.87%
$118.64
price up icon 10.48%
$99.85
price up icon 1.01%
biotechnology ONC
$337.89
price up icon 5.47%
$175.97
price up icon 3.35%
Kapitalisierung:     |  Volumen (24h):